These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6094200)

  • 21. Expression of various tumor-specific antigens in polyoma virus-induced tumors.
    Ting CC; Lavrin DH; Takemoto KK; Ting RC; Herberman RB
    Cancer Res; 1972 Jan; 32(1):1-6. PubMed ID: 4332472
    [No Abstract]   [Full Text] [Related]  

  • 22. Polyoma T-antigen-derived synthetic peptides induce polyoma-virus-specific macrophage migration inhibition.
    Reinholdsson G; Ramqvist T; Szigeti R; Dalianis T
    Int J Cancer; 1989 Jun; 43(6):1165-8. PubMed ID: 2543648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of a polyoma virus-induced tumor-associated membrane antigen in mouse cells by the macrophage migration inhibition test.
    Ramqvist T; Dalianis T; Reinholdsson G; Klein G; Szigeti R
    Cancer Res; 1986 Oct; 46(10):5045-8. PubMed ID: 3019520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility to polyoma virus tumorigenesis in X-linked immunodeficient (XID) and B-cell deficient (microMT) mice is not increased.
    Heidari S; Berke Z; Berglöf A; Woldegiorgis A; Smith CI; Dalianis T
    In Vivo; 1999; 13(6):439-44. PubMed ID: 10757034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells.
    Tomecki J; Mara M
    Neoplasma; 1987; 34(1):15-22. PubMed ID: 3031518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). I. Specificity of immunoprotection and effect of enzyme treatment on TSTA activity.
    Ansel S; Huet C; Tournier P
    Int J Cancer; 1977 Jul; 20(1):51-60. PubMed ID: 71274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen.
    Lukacher AE; Ma Y; Carroll JP; Abromson-Leeman SR; Laning JC; Dorf ME; Benjamin TL
    J Exp Med; 1995 May; 181(5):1683-92. PubMed ID: 7722447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice.
    Law LW; Takemoto KK; Rogers MJ; Henriksen O; Ting RC
    Int J Cancer; 1978 Sep; 22(3):315-22. PubMed ID: 212373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcellular distribution of the tumor-specific transplantation antigen of simian virus 40-transformed cells.
    Rogers MJ; Law LW; Appella E
    J Natl Cancer Inst; 1977 Oct; 59(4):1291-5. PubMed ID: 198559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS; Mylin LM; Fu TM; Tevethia SS
    Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyoma antigen driven T lymphocytes with antitumor and DTH activity in CBA mice.
    Ochałek T; Cadel Z
    Neoplasma; 1988; 35(3):271-8. PubMed ID: 3261395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of immunization of Syrian hamsters with tumor cells treated with glutaraldehyde on transplantation immunity and the cytotoxic effect of lymphocytes on polyoma tumor cells.
    Tomecki J
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):209-17. PubMed ID: 220931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Divergence between delayed-type hypersensitivity (DTH) to polyoma tumor-associated antigen and antitumor efficacy in polyoma-bearing recipients of therapeutic non-cytolytic, DTH-mediating lymphocytes.
    Ochalek T
    Immunol Lett; 1993 Oct; 38(2):97-102. PubMed ID: 8294146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of polyoma-induced transplantation antigen in hybrid cell lines.
    Klein G; Harris H
    Nat New Biol; 1972 Jun; 237(75):163-4. PubMed ID: 4338519
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies of the immune response against a polyoma virus-induced fibrosarcoma in BALB mice using the Winn's tumor neutralization assay.
    de Lapeyrière O; Imbert J; Cot E; Meyer G
    Bull Cancer; 1981; 68(2):101-8. PubMed ID: 6263382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunity to polyoma virus infection and tumorigenesis.
    Moser JM; Lukacher AE
    Viral Immunol; 2001; 14(3):199-216. PubMed ID: 11572632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologic and biochemical properties of detergent-solubilized tumor-specific transplantation antigen from a simian virus 40-induced neoplasm: brief communication.
    Natori T; Law LW; Appella E
    J Natl Cancer Inst; 1977 Oct; 59(4):1331-3. PubMed ID: 198560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the blood-brain barrier in the establishment of the immune response against polyoma virus-induced cerebral tumours in hamsters.
    de Micco C; Hassoun J; Meyer G; Toga M
    J Neuroimmunol; 1986 Jun; 11(4):301-10. PubMed ID: 3011857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologically detectable specific and cross-reactive antigens on the membrane of a polyoma virus-induced murine tumor.
    Witz IP; Lee N; Klein G
    Int J Cancer; 1976 Aug; 18(2):243-9. PubMed ID: 60289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of fetal antigens in tumor cells.
    Ting CC; Lavrin DH; Shiu G; Herberman RB
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1664-8. PubMed ID: 4340152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.